Table 2.
Association between etiology of infertility and IVF outcomes in autologous cycles
| Etiology (n) | Clinical pregnancy rate** N (%) |
p value | Live birth rate** N (%) |
p value | Miscarriage rate** N (%) |
p value | Multiple birth rate** N (%) |
p value | Adjusted p value*** |
|---|---|---|---|---|---|---|---|---|---|
| DOR* (390) | 235 (60.3%) | 0.68 | 201 (51.5) | 0.95 | 33 (8.5%) | 0.83 | 25 (6.4%) | 0.91 | 0.29 |
| TF* (101) | 60 (59.4%) | 49 (48.5%) | 11 (10.9%) | 6 (6.0%) | 0.58 | ||||
| Endo* (64) | 36 (56.3%) | 32 (50%) | 4 (6.3%) | 6 (9.4%) | 0.78 | ||||
| PCOS* (226) | 137 (60.6%) | 117 (51.8%) | 19 (8.4%) | 18 (8.0%) | 0.11 | ||||
| MF* (384) | 230 (59.9%) | 202 (52.6%) | 28 (7.3%) | 34 (8.9%) | 0.36 | ||||
| Uterine (65) | 45 (69.2%) | 36 (55.4%) | 8 (12.3%) | 4 (6.2%) | 0.32 | ||||
| Unexpl* (495) | 312 (63.0%) | 267 (53.9%) | 45 (9.1%) | 39 (7.9%) | 0.63 | ||||
| Other (671) | 426 (63.5%) | 363 (54.1%) | 63 (9.4%) | 39 (9.0%) | 0.96 |
*DOR, diminished ovarian reserve; TF, tubal factor; Endo, endometriosis; PCOS, polycystic ovarian syndrome; MF, male factor; Unexpl, unexplained
**Per embryo transfer cycle
***p values adjusted for BMI